New Study Finds Medical Marijuana Doesn’t Help Anxiety and Depression and Doubles Addiction Risk

Using medical marijuana to treat pain, anxiety and depression failed to improve these symptoms while doubling the risk of developing cannabis use disorder, according to a new study published in JAMA Network Open. The study by Massachusetts General Hospital (MGH) followed 269 adults from the Boston area with an average age of 37 who wanted to obtain medical marijuana cards.

Learn more: https://www.euronews.com/next/2022/03/24/medical-marijuana-doesn-t-help-anxiety-and-depression-and-doubles-addiction-risk-new-study

← Prev: Dose Tapering, Increases and Discontinuity Among Patients on Long-term High-dose Opioid Therapy Next: DOD Study: U.S. Soldiers Not Receiving Alcohol Abuse Treatment They Need →

UN Drug Report Shines Light on Cannabis, Cocaine and Methamphetamine Trends

August 11, 2022

The World Drug Report 2022 also details the environmental consequences of the illicit drugs trade, the expansion of...

Evaluating Disparities in Prescribing of Naloxone after ED Treatment of Opioid Overdose

August 9, 2022

Patients who initially survive opioid-related overdose are at high risk for subsequent mortality. This retrospective...

Study of Mortality in Adult Children of Parents with Alcohol Use Disorder

August 4, 2022

More than sixty million people worldwide have alcohol use disorder (AUD). Millions of children grow up with at least...

New Study Finds Medical Marijuana Doesn’t Help Anxiety and Depression and Doubles Addiction Risk

You May Also Like…

UN Drug Report Shines Light on Cannabis, Cocaine and Methamphetamine Trends

Evaluating Disparities in Prescribing of Naloxone after ED Treatment of Opioid Overdose

Study of Mortality in Adult Children of Parents with Alcohol Use Disorder

0 Comments

Submit a Comment Cancel reply